Sigma Planning Corp
Source: SEC Form 13F · as of Mar 2026Sigma Planning Corp holds 15 biotech & pharma companies tracked by BioSniper, totaling $12.1M in value as of Mar 2026 (SEC Form 13F).
Companies held
15
Total value held
$12.1M
BioSniper AIPage evidence connected
Prepared research question
What matters most for GILEAD SCIENCES, INC. (GILD)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| GILDGILEAD SCIENCES, INC. | 20,278 | $2.8M |
| LQDALiquidia Corp | 60,085 | $2.3M |
| REGNREGENERON PHARMACEUTICALS, INC. | 2,012 | $1.6M |
| MRNAModerna, Inc. | 25,705 | $1.3M |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 22,713 | $1.3M |
| LGNDLigand Pharmaceuticals Incorporated | 4,500 | $898K |
| RNTXRein Therapeutics, Inc. | 348,677 | $453K |
| VKTXViking Therapeutics, Inc. | 13,700 | $446K |
| STROSUTRO BIOPHARMA, INC. | 12,520 | $312K |
| QUREuniQure N.V. | 16,900 | $276K |
| CGTXCOGNITION THERAPEUTICS INC | 337,765 | $257K |
| IBRXImmunityBio, Inc. | 17,715 | $136K |
| BHVNBiohaven Ltd. | 13,324 | $113K |
| OPKOPKO HEALTH, INC. | 15,807 | $18K |
| CUECue Biopharma, Inc. | 38,750 | $9K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.